Tsukuba, Japan

Toru Fujikawa

This inventor holds 3 USPTO granted patents. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 2004-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toru Fujikawa. Retrieved from https://idiyas.com/inventor/toru-fujikawa-3m9e4fah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.8

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2004-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Toru Fujikawa: Innovator in Amide Derivatives

Introduction

Toru Fujikawa is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on amide derivatives. With a total of 3 patents, Fujikawa's innovations are paving the way for advancements in medical treatments.

Latest Patents

One of his latest patents involves amide derivatives, which are compounds represented by a specific general formula. These compounds exhibit selective antagonism to muscarinic M receptors, making them useful as safe and effective agents for treating diseases of the respiratory, urinary, and digestive systems. This invention highlights Fujikawa's commitment to developing medications with minimal side effects.

Career Highlights

Fujikawa is currently associated with Banyu Pharmaceutical Co. Ltd., where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the company's portfolio but has also had a broader impact on the medical community.

Collaborations

Throughout his career, Fujikawa has collaborated with esteemed colleagues such as Toshifumi Kimura and Norikazu Otake. These partnerships have fostered an environment of innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Toru Fujikawa's contributions to the field of pharmaceuticals, particularly through his work on amide derivatives, demonstrate his dedication to improving medical treatments. His innovative spirit and collaborative efforts continue to inspire advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…